Cullen Mitsuo Taniguchi, MD, PhD
Affiliations: | 2000 | Economic and Social History | Linacre College, Oxford University |
2008 | Developmental Biology | Harvard Medical School, Boston, MA, United States | |
2009-2014 | Radiation Oncology | Stanford University, Palo Alto, CA | |
2014- | Radiation Oncology | The University of Texas MD Anderson Cancer Center |
Area:
Radiation Oncology; radiation protection; hypoxia; gastrintestinal cancersWebsite:
https://faculty.mdanderson.org/profiles/cullen_taniguchi.htmlGoogle:
"Cullen Taniguchi"Parents
Sign in to add mentorC. Ronald Kahn | grad student | 2005 | Harvard Medical School (Neurotree) | |
("The dissection of insulin signaling isoforms in vivo: Molecular mechanisms of hepatic insulin action") |
Children
Sign in to add traineeRamez Kouzy | post-doc | 2019-2021 | |
Lauren Colbert | research scientist | The University of Texas MD Anderson Cancer Center |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Colbert LE, El Alam MB, Wang R, et al. (2023) Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell |
Sherry AD, Msaouel P, McCaw ZR, et al. (2023) Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy. European Journal of Cancer (Oxford, England : 1990). 194: 113357 |
Sherry AD, Corrigan KL, Kouzy R, et al. (2023) Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research. Cancer |
Florez MA, Jaoude JA, Patel RR, et al. (2023) Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials. Jama Network Open. 6: e2313819 |
Elnaggar JH, Huynh VO, Lin D, et al. (2023) HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development. Frontiers in Immunology. 14: 1051431 |
Koay EJ, Zaid M, Aliru M, et al. (2022) Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation. International Journal of Radiation Oncology, Biology, Physics |
Lin D, Alam MBE, Jaoude JA, et al. (2022) Microbiome Dynamics During Chemoradiotherapy for Anal Cancer. International Journal of Radiation Oncology, Biology, Physics |
Moningi S, Lei X, Fang P, et al. (2022) Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer. Clinical and Translational Radiation Oncology. 35: 9-16 |
Okoro CM, Schüler E, Taniguchi CM. (2022) The Therapeutic Potential of FLASH-RT for Pancreatic Cancer. Cancers. 14 |
Delahoussaye AM, Abi Jaoude J, Green M, et al. (2022) Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model. Bmc Cancer. 22: 174 |